Status:

WITHDRAWN

Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

Lead Sponsor:

George Washington University

Collaborating Sponsors:

National Institute on Minority Health and Health Disparities (NIMHD)

Shenandoah University

Conditions:

Thrombosis; Artery

Eligibility:

All Genders

18-70 years

Brief Summary

The purpose of this pilot study is to determine how the anti-platelet drug, ticagrelor, impacts platelet mRNA splicing after a single loading dose in 10 healthy participants. These results will be val...

Detailed Description

There is nothing known on how differential splicing in platelets is impacted by of P2Y12 inhibition by anti-platelet agents. Consequently, the focus of this longitudinal pilot study will be to determi...

Eligibility Criteria

Inclusion

  • 18 - 70 years-old
  • Speak and understand English

Exclusion

  • History of blood clotting/bleeding disorders
  • Current medications that are CYP3A4 inhibitors/inducers
  • Current medications that their pharmacokinetics is impacted by ticagrelor (i.e. simvastatin, lovastatin, digoxin) per FDA recommendations.
  • Diagnosed with arterial or venous thrombosis
  • Active cancer diagnosis
  • Pregnant
  • Hepatic impairment including active hepatitis infection or cirrhosis
  • Current hormonal contraception
  • Currently taking aspirin or anti-platelet drugs. If patient has recently taken an NSAID, the last dose should have been discontinued based established criteria

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 23 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04088123

Start Date

April 1 2020

End Date

September 23 2020

Last Update

October 28 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The George Washington University School of Medicine and Health Sciences

Washington D.C., District of Columbia, United States, 20037

2

Shenandoah University Bernard J. Dunn School of Pharmacy

Fairfax, Virginia, United States, 22601